The conserved target of rapamycin (TOR) kinases regulate many aspects of cellular physiology. They exist in two distinct complexes, termed TOR complex 1 (TORC1) and TOR complex 2 (TORC2), that posses both overlapping and distinct components. TORC1 and TORC2 respond differently to the drug rapamycin and have different cellular functions: whereas the rapamycin-sensitive TORC1 controls many aspects of cell growth and has been characterized in great detail, the TOR complex 2 is less understood and regulates actin polymerization, cell polarity, and ceramide metabolism. How signaling specificity and discrimination between different input signals for the two kinase complexes is achieved is not understood. Here, we show that TORC1 and TORC2 have different localizations in Saccharomyces cerevisiae. TORC1 is localized exclusively to the vacuolar membrane, whereas TORC2 is localized dynamically in a previously unrecognized plasma membrane domain, which we term membrane compartment containing TORC2 (MCT). We find that plasma membrane localization of TORC2 is essential for viability and mediated by lipid binding of the C-terminal domain of the Avo1 subunit. From these data, we suggest that the TOR complexes are spatially separated to determine downstream signaling specificity and their responsiveness to different inputs.
INTRODUCTIONDuring cell growth and division, many physiological processes need to be coordinated and modified according to nutrient availability. Signaling through target of rapamycin (TOR) kinases plays a central role in this regulation. Even though TOR kinases are related to phosphoinositide lipid kinases, they are Ser/Thr protein kinases, with a small number of known targets that regulate many cellular processes. Together, the diverse TOR signaling outputs regulate cell growth, both spatially and temporally (De Virgilio and Loewith, 2006;Reiling and Sabatini, 2006;Wullschleger et al., 2006).The characterization of TOR signaling was greatly aided by the discovery of the antifungal and immunosuppressant macrocyclic lactone rapamycin. The search for targets of this drug in the yeast Saccharomyces cerevisiae lead to the discovery of the TOR kinases and subsequently helped to identify their molecular function (Heitman et al., 1991).The rapamycin-sensitive branch of TOR signaling regulates processes that collectively modulate the rate of cell growth. TOR signaling is active under conditions of excess nutrients, blocking catabolic processes, such as autophagy and stress responses. In contrast, exposure to rapamycin or withdrawal of nitrogen or carbon sources lead to inactivation of TOR signaling and down-regulation of anabolic processes, such as protein synthesis. Together these processes coordinate cell growth with nutrient availability (De Virgilio and Loewith, 2006;Wullschleger et al., 2006). This function of TOR signaling is performed by TOR complex 1 (TORC1) that consists of the kinase plus three additional subunits in yeast, named Lst8, Kog1, and Tco89 or two subunits named raptor and mLst8 in mammals. Its...